TVRD
Tvardi Therapeutics, Inc.
1.30$
+19.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| -4.1% | -260.9% | -42.7% | -439.1% | -853.5% | – | |
| 0.8% | 6.7% | 0.2% | 1.2% | 2.7% | – | |
| – | – | 0.6% | 1.5% | 4.5% | – | |
| -5.5% | 22.9% | 6.4% | 48.5% | -211.6% | – | |
| 0.3% | 0.2% | 0.1% | 11.3% | 14.7% | – | |
| -15.0% | -20.6% | -52.5% | 207.3% | 682.9% | – | |
| – | – | – | – | 396.5% | – | |
| 29.0% | 202.4% | 0.0% | 181.9% | -50.5% | – | |
| 9.9% | -79.2% | -95.2% | -57.1% | -200.1% | – | |
| -4.3% | -261.1% | -42.8% | -450.5% | -868.2% | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.